AGRAWAL SUDHIR has a total of 33 patent applications. Its first patent ever was published in 1994. It filed its patents most often in WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are IDERA PHARMACEUTICALS INC, COLEY PHARM GMBH and ISOGENIS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 23 | |
#2 | United States | 10 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Environmental technology | |
#5 | Medical technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Microorganisms | |
#3 | Medical preparations | |
#4 | Sugars | |
#5 | Climate change adaptation technologies | |
#6 | Measuring microorganism processes | |
#7 | Electrotherapy |
# | Name | Total Patents |
---|---|---|
#1 | Agrawal Sudhir | 33 |
#2 | Yu Dong | 19 |
#3 | Kandimalla Ekambar R | 17 |
#4 | Wang Daqing | 14 |
#5 | Bhagat Lakshmi | 13 |
#6 | Putta Mallikarjuna | 10 |
#7 | Kandimalla Ekambar | 10 |
#8 | Lan Tao | 5 |
#9 | Lakshmi Bhagat | 2 |
#10 | Zhu Fu-Gang | 2 |
Publication | Filing date | Title |
---|---|---|
WO2020191177A1 | Antisense oligonucleotides for allele specificity | |
WO2021055011A1 | Compounds and methods useful for modulating gene splicing | |
US2013142778A1 | Compositions for inhibiting gene expression and uses thereof | |
WO2011005942A2 | Oligonucleotide-based compounds as inhibitors of toll-like receptors |